Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 242 entries
View as:

Comparable Study of Different Radiation Dose in Esophageal Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT01937208 Org: User:
Start: 08/31/13 End: 07/31/17 Due: 07/31/18

Zoladex Plus Tamoxifen in Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00827307 Org: User:
Start: 06/30/08 End: 08/31/11 Due: 08/31/12

RLC Followed by CR-CHOP in Elderly Patients with Newly-diagnosed DEL

Phase: N/A Priority: Normal
NCT ID: NCT06674096 Org: User:
Start: 11/06/24 End: 06/30/30 Due: 06/30/31

HIPEC, Intravenous Chemotherapy and Surgery for the Treatment of Advanced GC With Peritoneal Metastasis

Phase: N/A Priority: Normal
NCT ID: NCT02549911 Org: User:
Start: 09/30/15 End: 09/30/17 Due: 09/30/18

Surufatinib Plus Cadonilimab in Patients With Unresectable or Metastatic Bile Duct Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT06092645 Org: User:
Start: 10/30/23 End: 10/31/25 Due: 10/31/26

Cetuximab in Combination With Dabrafenib and Tislelizumab in BRAF Mutated Treatment of Advanced Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05963087 Org: User:
Start: 08/31/23 End: 06/30/26 Due: 06/30/27

TRT for ES-SCLC After First Line Treatment With Immune Checkpoint Inhibitors

Phase: N/A Priority: Normal
NCT ID: NCT05544149 Org: User:
Start: 09/01/22 End: 08/30/25 Due: 08/30/26

ZR2 Followed by Immunochemotherapy in Elderly Patients With Newly-diagnosed DLBCL

Phase: N/A Priority: Normal
NCT ID: NCT05290090 Org: User:
Start: 10/01/21 End: 12/01/25 Due: 12/01/26

Establishment of Tongue Image Database and Machine Learning Model for Malignant Tumors Diagnosis

Phase: N/A Priority: Normal
NCT ID: NCT04793672 Org: User:
Start: 05/01/20 End: 12/01/23 Due: 12/01/24

Efficacy Study of Neoadjuvant Chemotherapy With Chemoradiation Therapy for Nasopharyngeal Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT01536223 Org: User:
Start: 04/30/12 End: 02/28/15 Due: 02/28/16

Endostatin in Combination With Chemotherapy for Metastatic Nasopharyngeal Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT01915134 Org: User:
Start: 08/31/13 End: 12/31/16 Due: 12/31/17

Development of Novel Gastric Cancer Screening and Diagnosis Technologies Using Tongue Imaging and Study of Tongue Image Changes Mechanisms

Phase: N/A Priority: Normal
NCT ID: NCT06078930 Org: User:
Start: 06/01/21 End: 12/31/26 Due: 12/31/27

Correlation Between Molecular Typing and Neoadjuvant Chemotherapy in Breast Cancer Patients Based on Mammaprint/Blueprint Test

Phase: N/A Priority: Normal
NCT ID: NCT04264468 Org: User:
Start: 05/14/19 End: 03/01/21 Due: 03/01/22

A Clinical Study to Explore the Efficacy and Safety of Tislelizumab in Combination With Bevacizumab and Chemotherapy in Patients With Persistent, Recurrent, or Metastatic Cervical Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05247619 Org: User:
Start: 06/30/22 End: 01/31/25 Due: 01/31/26

Dalpiciclib Combination With Fulvestrant and Compound Gossyfol Acetate Tablets in Women With CDK4/6 Inhibitor-refractory HR-positive HER-2 Negtive Metastatic Breast Cancer: a Phase 2 Clinical Trial.

Phase: N/A Priority: Normal
NCT ID: NCT06133088 Org: User:
Start: 08/01/23 End: 08/31/25 Due: 08/31/26

Individualized Pharmaceutical-care for Inpatients With Cancer Pain

Phase: N/A Priority: Normal
NCT ID: NCT03455023 Org: User:
Start: 06/30/18 End: 06/30/19 Due: 06/30/20

Esketamine for Prevention of Depression After Cytoreductive Surgery in Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06624878 Org: User:
Start: 10/08/24 End: 12/31/26 Due: 12/31/27

The Role of Clean Intermittent Catheterization in Patients Undergoing Radiotherapy After Radical Hysterectomy for Cervical Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05410444 Org: User:
Start: 07/01/18 End: 03/01/21 Due: 03/01/22

Chemoradiotherapy With or Without Sintilimab in Limited-stage SCLC

Phase: N/A Priority: Normal
NCT ID: NCT04189094 Org: User:
Start: 01/01/20 End: 07/01/23 Due: 07/01/24

Erlotinib Combined With Radiotherapy in Patients With Non-resectable Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT01091376 Org: User:
Start: 01/31/10 End: 03/31/13 Due: 03/31/14

A Clinical Study Of Camrelizumab With Or Without Radiotherapy In The Treatment Of Esophageal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04512417 Org: User:
Start: 08/31/20 End: 08/31/22 Due: 08/31/23

PCI and Brain MRI Follow-up vs Brain MRI Follow-up Alone in Limited-stage SCLC Patients

Phase: N/A Priority: Normal
NCT ID: NCT05651802 Org: User:
Start: 01/01/23 End: 06/30/26 Due: 06/30/27

Preoperative Systemic Therapy vs Upfront Surgery in HER2 Positive Early Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04249440 Org: User:
Start: 01/01/12 End: 03/30/20 Due: 03/30/21

XPO-1 in Combination With RCHOP for DH/TH Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT05974085 Org: User:
Start: 08/01/22 End: 03/01/24 Due: 03/01/25

Durvalumab Combined With Chemotherapy and Stereotactic Body Radiotherapy (SBRT) in Patients With Oligometastatic Non-small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT04255836 Org: User:
Start: 09/30/20 End: 07/30/23 Due: 07/30/24